Immunopathology of RSV: an updated review
RSV is a leading cause of respiratory tract disease in infants and the elderly. RSV has
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …
limited therapeutic interventions and no FDA-approved vaccine. Gaps in our understanding …
Bronchiolitis needs a revisit: distinguishing between virus entities and their treatments
Current data indicate that the “bronchiolitis” diagnosis comprises more than one condition.
Clinically, pathophysiologically, and even genetically three main clusters of patients can be …
Clinically, pathophysiologically, and even genetically three main clusters of patients can be …
Short-chain fatty acid acetate triggers antiviral response mediated by RIG-I in cells from infants with respiratory syncytial virus bronchiolitis
Background Gut microbiota-derived short-chain fatty-acid (SFCA) acetate protects mice
against RSV A2 strain infection by increasing interferon-β production and expression of …
against RSV A2 strain infection by increasing interferon-β production and expression of …
Nebulised ALX-0171 for respiratory syncytial virus lower respiratory tract infection in hospitalised children: a double-blind, randomised, placebo-controlled, phase 2b …
S Cunningham, PA Piedra… - The Lancet …, 2021 - thelancet.com
Background Respiratory syncytial virus (RSV) is the most common cause of severe lower
respiratory tract infection, with a high global health burden. There are no effective treatments …
respiratory tract infection, with a high global health burden. There are no effective treatments …
Neutrophilic inflammation in the respiratory mucosa predisposes to RSV infection
INTRODUCTION Even with intimate exposure to a virus, some people fail to become
infected. Variable transmission partly depends on the dose and duration of exposure but is …
infected. Variable transmission partly depends on the dose and duration of exposure but is …
[HTML][HTML] Respiratory syncytial virus: from pathogenesis to potential therapeutic strategies
Z Shang, S Tan, D Ma - International Journal of Biological Sciences, 2021 - ncbi.nlm.nih.gov
Respiratory syncytial virus (RSV) is one of the most important viral pathogens causing
respiratory tract infection in infants, the elderly and people with poor immune function, which …
respiratory tract infection in infants, the elderly and people with poor immune function, which …
Early-life respiratory syncytial virus disease and long-term respiratory health
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection
(LRTI), hospital admission, and mortality in children worldwide. Early-life RSV LRTI has also …
(LRTI), hospital admission, and mortality in children worldwide. Early-life RSV LRTI has also …
Single cell transcriptomics identifies distinct profiles in pediatric acute respiratory distress syndrome
Acute respiratory distress syndrome (ARDS), termed pediatric ARDS (pARDS) in children, is
a severe form of acute respiratory failure (ARF). Pathologic immune responses are …
a severe form of acute respiratory failure (ARF). Pathologic immune responses are …
Respiratory syncytial virus (RSV): a scourge from infancy to old age
Respiratory syncytial virus (RSV) is the most common single cause of respiratory
hospitalisation of infants and is the second largest cause of lower respiratory infection …
hospitalisation of infants and is the second largest cause of lower respiratory infection …
[HTML][HTML] Does respiratory syncytial virus lower respiratory illness in early life cause recurrent wheeze of early childhood and asthma? Critical review of the evidence …
Respiratory syncytial virus (RSV) is a leading cause of lower respiratory tract infection (LRTI)
and hospitalization in infants and children globally. Many observational studies have found …
and hospitalization in infants and children globally. Many observational studies have found …